According to Enzo Biochem's latest financial reports the company's current EPS (TTM) is -$1.59. In 2022 the company made an earnings per share (EPS) of -$0.93 a decrease over its 2021 EPS that were of $0.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.53 | 63.88% |
2022 | -$0.93 | -650% |
2021 | $0.17 | -123.26% |
2020 | -$0.73 | -2250% |
2019 | $0.03387 | -106.06% |
2018 | -$0.56 | 1018.34% |
2017 | -$0.04997 | -103.47% |
2016 | $1.44 | 507.14% |
2015 | $0.24 | -156% |
2014 | -$0.42 | -43.18% |
2013 | -$0.75 | -55.56% |
2012 | -$1.68 | 130.23% |
2011 | -$0.73 | -24.56% |
2010 | -$0.97 | 14% |
2009 | -$0.85 | 16.28% |
2008 | -$0.73 | 19.44% |
2007 | -$0.61 | -16.28% |
2006 | -$0.73 | 79.17% |
2005 | -$0.41 | -1300% |
2004 | $0.03387 | -263.03% |
2003 | -$0.02078 | -104.34% |
2002 | $0.48 | 28.8% |
2001 | $0.37 | -2.16% |
2000 | $0.38 | -6.51% |
1999 | $0.41 | 93.68% |
1998 | $0.21 | 85.84% |
1997 | $0.11 | -122.52% |
1996 | -$0.50 |